EN
HI
Strides Pharma Science Share Price
1219.819.60 (1.63%)
NSE
BSE
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Summary
As of 20 Sep, 2026, Strides Pharma Science stock price is ₹1219.8. During the trading session, the stock has moved between an intraday low of ₹1200.00 and an intraday high of ₹1229.40. Over the last 52 weeks, Strides Pharma Science has traded between ₹768.65 and ₹1231.00.
The stock has recorded a trading volume of 2,82,913 shares,. Its Average Traded Price (ATP) is ₹1214.71, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 3 @ ₹1219.80.
Strides Pharma Science has an upper circuit limit of ₹1463.70 and a lower circuit limit of ₹975.90. The total value traded stands at ₹34.37 CR, and the delivery percentage for the day is 46.7%.
The stock is currently traded with a market lot size of 1. Strides Pharma Science also offers a dividend yield of 0.41%.
Strides Pharma Science Share Price Chart
Strides Pharma Science Share Key Metrics
Volume
2.83 L
Market Cap
11243.23 CR
LTQ@LTP
3@1219.80
ATP
1214.71
Var Margin
19.84 %
Circuit Range
975.9-1463.7
Delivery %
46.7 %
Value
34.37 CR
ASM/GSM
No
Market Lot
1
Strides Pharma Science Resistance and Support
Pivot 1192.37
Resistance
First Resistance
1222.74
Second Resistance
1245.27
Third Resistance
1275.64
Support
First Support
1169.84
Second Support
1139.47
Third Support
1116.94
Strides Pharma Science Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
27.91%
Mutual Fund
8.73%
Insurance
4.99%
Foreign Institutional Investors
28.4%
Domestic Institutional Investors
1.69%
Retail
28.28%
Others
0%
Total Promoters
MAR '26
27.91%
JUN '26
27.91%
Strides Pharma Science Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-31 | Quarterly Results |
| 2026-05-18 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results |
| 2025-10-31 | Quarterly Results |
| 2025-07-29 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-01-30 | Quarterly Results |
| 2024-10-24 | Quarterly Results |
| 2024-07-29 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-31 | 2026-07-31 | View More |
Strides Pharma Science News
Strides Pharma Science Ltd - 532531 - Completion Of USFDA Inspection At The Company''s Formulations Facility At Alathur
Strides Pharma Science's Alathur facility concluded a USFDA cGMP inspection from Sep 2-11, 2026. The USFDA issued a Form 483 with three observations, which the company will address promptly.
Sep 11 2026 21:47:23
Strides Pharma Science Management
| Name | Position |
|---|---|
| Arun Kumar | Chairman |
| Kausalya Santhanam | Non Executive Independent Director |
Strides Pharma Science Similar Stocks
Alivus Life Sciences Ltd.
1430.80
43.00 (3.10%)
Akums Drugs & Pharmaceuticals Ltd.
783.70
17.00 (2.22%)
Metropolis Healthcare Ltd.
597.45
11.15 (1.90%)
Park Medi World Ltd.
282.05
4.15 (1.49%)
Sanofi Consumer Healthcare India Ltd.
4033.40
43.90 (1.10%)
Blue Jet Healthcare Ltd.
575.25
7.05 (1.24%)
Viyash Scientific Ltd.
249.65
5.15 (2.11%)
Healthcare Global Enterprises Ltd.
708.25
21.10 (3.07%)
Suven Life Sciences Ltd.
341.55
-8.30 (2.37%)
Yatharth Hospital & Trauma Care Services Ltd.
1139.50
67.10 (6.26%)
Strides Pharma Science FAQs
The Buying Price of Strides Pharma Science share is 1219.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Strides Pharma Science stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Strides Pharma Science, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Strides Pharma Science shares is 18.33. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Strides Pharma Science shares is 3.43. Useful to assess the stock's value relative to its book value.
To assess Strides Pharma Science’s valuation compare Sector P/E, P/B which are 42.35 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Strides Pharma Science is 11243.23 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Strides Pharma Science share price is 1231.00 & 768.65. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Strides Pharma Science belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in STAR
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC